Related Experiment Video
Updated: Sep 11, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Factors associated with sedentary behavior among breast cancer patients during chemotherapy: A cross-sectional study
Ye Yang1,2, Wei Jia1,2, Kaiping Wu1
1Department of Breast Surgery, The Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, China.
Abstract:
Sedentary behavior (SB) is one of the prevalent unhealthy behaviors among breast cancer (BC) patients during chemotherapy and is associated with a variety of adverse health outcomes. Employing a comprehensive theoretical framework to identify the key determinants of SB is a critical step in developing targeted, evidence-based interventions. The purpose of this study was to explore the determinants of SB by using the Capability, Opportunity, Motivation - Behavior model. A cross-sectional survey was conducted and 234 BC patients during chemotherapy were conveniently recruited from a tertiary hospital. The participants completed measures of SB, shoulder function, common cancer-related symptoms, fatigue, exercise self-efficacy, depression, social support, neighborhood built environment, and sociodemographic and clinical characteristics. Descriptive statistics, univariate analysis, Pearson correlation analysis, and multiple linear regression were applied for data analysis. Multiple linear regression results showed that exercise self-efficacy, depression, fatigue, shoulder function, instrumental support, informational support, age, residence status, work status, body mass index, and cancer stage were the main influencing determinants of SB and explained 33.46% of the variance. Findings support the Capability, Opportunity, Motivation - Behavior model's explanatory potential in the context of BC patients' SB and also provide reasonable targets for a behavioral intervention for reducing SB.
Related Concept Videos
Cancer Prevention
Some...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Cancer Survival Analysis
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...

